Procedure |
POINT
OF CARE TESTING ON THE I-STAT PORTABLE ANALYZER |
Prepared by |
Date Adopted |
Supersedes Procedure |
|
|
New Procedure |
Review Date |
Revision Date |
Signature |
|
|
|
|
|
|
|
|
|
|
|
|
Distributed to |
No.
of Copies |
Distributed to |
No.
of Copies |
Anesthesia
Department |
1 |
|
|
Pathology
Department |
1 |
|
|
|
|
|
|
|
|
|
|
PRECAUTION:
WHILE PERFORMING THIS PROCEDURE, THE FOLLOWING SAFETY
MEASURES MUST BE TAKEN: GLOVES MUST BE WORN; SMOKING, EATING, DRINKING,
APPLICATION OF COSMETICS, AND
MANIPULATION OF CONTACT LENSES ARE
PROHIBITED IN ALL TECHNICAL WORK AREAS.
REFER TO THE UNIVERSAL PRECAUTIONS POLICIES. |
CLIA
Complexity: Moderate
I.
SYSTEM OVERVIEW:
The
I‑STAT System incorporates comprehensive components needed to perform
blood analysis at the point of care.
The System consists of the following primary components:
A.
Cartridges
A single‑use disposable cartridge
contains a microfabricated sensor array, a calibrant solution, fluidics system,
and a waste chamber. Sensors for
analysis of sodium, potassium, chloride, ionized calcium, pH, PCO2, PO2, urea
nitrogen (BUN), glucose, and hematocrit are available in a variety of panel
configurations (see Table 1). A whole
blood sample of approximately 2 to 4 drops is dispensed into the cartridge
sample well.
B.
Analyzer
A hand‑held analyzer into which
the blood‑filled cartridge is placed for analysis automatically controls
all functions of the testing cycle including fluid movement within the
cartridge, calibration, and continuous quality monitoring. Analyzers with thermal control capability
for testing at 370 C and cartridges requiring thermal control are
labeled with a 37° symbol.
C.
Central Data Station
A dedicated desktop computer, called
the I‑STAT Central Data Station,
provides the primary information management capabilities for the I‑STAT
System. IR Links allow for transmission
of patient records from a widely distributed network of analyzers to the
Central Data Station. Data can be
stored, organized, edited and transferred to a laboratory information system or
other computer.
Table I. Cartridge Panel Configurations
Cartridge Symbol |
Sample vol.,ul |
Na |
K |
Cl |
BUN |
Glu |
iCa |
pH |
PCO2 |
PO2 |
Hct |
HCO3 |
TCO2 |
sO2 |
BE |
Gap |
Hb |
G |
65 |
|
|
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
E3+ |
65 |
* |
* |
|
|
|
|
|
|
|
* |
|
|
|
|
|
* |
EC4+ |
65 |
* |
* |
|
|
* |
|
|
|
|
* |
|
|
|
|
|
* |
6+ |
65 |
* |
* |
* |
* |
* |
|
|
|
|
* |
|
|
|
|
|
* |
EC6+ |
65 |
* |
* |
|
|
* |
* |
* |
|
|
* |
|
|
|
|
|
* |
EC8+ |
65 |
* |
* |
* |
* |
* |
|
* |
* |
|
* |
* |
* |
|
|
* |
* |
G3+ |
95 |
|
|
|
|
|
|
* |
* |
* |
|
* |
* |
* |
* |
|
|
EG6+ |
95 |
* |
* |
|
|
|
|
* |
* |
* |
* |
* |
* |
* |
* |
|
* |
EG7+ |
95 |
* |
* |
|
|
|
* |
* |
* |
* |
* |
* |
* |
* |
* |
|
* |
Note: shades areas are calculated
values
II.
CLINICAL SIGNIFICANCE:
Analyte |
Some
Causes of Increased Values |
Some
Causes of Decreased Values |
Sodium |
Dehydration Diabetes
insipidus Salt
poisoning Skin
losses Hyperaldosteronism CNS
disorders |
Dilutional
Hyponatremia (cirrhosis) Depletional
Hyponatremia Syndrome
of inappropriate ADH |
Potassium |
Renal
glomerular disease Adrenocortical
insufficiency Diabetic
Ketoacidosis (DKA) Sepsis In
vitro hemolysis |
Renal
tubular disease Hyperaldosteronism Treatment
of DKA Hyperinsulinism Metabolic
alkalosis Diuretic
therapy |
Chloride |
Prolonged
diarrhea Renal
tubular disease Hyperparathyroidism Dehydration |
Prolonged
vomiting Burns Salt-losing
renal disease Overhydration Thiazide
therapy |
Ionized
Calcium |
Dehydration Hyperparathyroidism Malignancies Immobilization Thiazide
diuretics Vitamin
D intoxication |
Hypoparathyroidism Early
neonatal hypocalcemia Chronic
renal disease Pancreatitis Massive
blood transfusions Severe
malnutrition |
BUN |
Impaired
renal function Prerenal
azotemia (e.g. shock) Postrenal
azotemia GI
bleeding High
protein diet |
Pregnancy Severe
liver insufficiency Overhydration Malnutrition |
Glucose |
Diabetes
mellitus Pancreatitis Endocrine
disorders (e.g. Cushings syndrome) Drugs
(e.g. steroids, thyrotoxicosis) Chronic
renal failure Stress IV
glucose infusion |
Insulinomea Adrenocortical
insufficiency Hypopituitarism
/Massive liver disease Ethanol
ingestion/Reactive hypoglycemia Glycogen
storage disease |
Analyte |
Some
Causes of Increased Values |
Some
Causes of Decreased Values |
pH |
Respiratory
alkalosis Metabolic alkalosis |
Respiratory
acidosis Metabolic acidosis |
PCO2 |
Acute
Respiratory Acidosis: §
Depression of respiratory center §
Suppresses neuromuscular system §
Pulmonary disorders §
Inadequate mechanical ventilation Chronic
Respiratory Acidosis: §
Decreased alveolar ventilation §
Hypoventilation Compensation
in metabolic alkalosis |
Respiratory
Alkalosis: §
Increased stimulation of respiratory center §
Hypermetabolic states §
Mechanical hyperventilation Compensation
in metabolic acidosis |
PO2 |
Breathing
oxygen-enriched air |
Carbon-monoxide
exposure Pulmonary
disorders Myocardial
infarction Congestive
heart failure |
HCO3 |
Primary
metabolic alkalosis Primary
respiratory acidosis |
Primary
metabolic acidosis Primary
respiratory alkalosis |
Hematocrit |
Dehydration Burns Impaired
ventilation Renal disorders |
Hemolytic
anemias Iron
deficiency Marrow
depression Blood loss |
III.
PRINCIPLES OF MEASUREMENT :
Sodium,
Potassium, Chloride, Ionized Calcium, pH and PCO2 are measured by ion‑selective
electrode potentiometry. Concentrations
are calculated from the measured potential through the Nernst equation.
Urea is first hydrolyzed to ammonium
ions in a reaction catalyzed by the enzyme urease. The ammonium ions are measured by an ion‑selective
electrode and the concentration is calculated from the measured potential through
the Nernst equation.
Glucose is measured
amperometrically. Oxidation of glucose,
catalyzed by the enzyme glucose oxidase, produces hydrogen peroxide. The liberated hydrogen peroxide is oxidized
at an electrode to produce an electric current which is proportional to the
glucose concentration.
PO2 is measured amperometrically. The oxygen sensor is similar to a
conventional Clark electrode. Oxygen
permeates through a gas permeable membrane from the blood sample into an
internal electrolyte solution where it is reduced at the cathode. The oxygen reduction current is proportional
to the dissolved oxygen concentration.
Hematocrit
is determined conductometrically. The
measured conductivity, after correction for electrolyte concentration, is
inversely related to the hematocrit.
IV. BLOOD SPECIMENS:
A.
Blood Volume: See Table I above.
B. Specimen Requirements: Verify
patient’s identity by looking at the arm band.
§
Fresh whole blood collected in a capillary tube or a plastic
syringe without anticoagulant (Test
within 3 minutes of collection)
§
Fresh whole blood collected in a capillary tube with lithium
or sodium heparin anticoagulant (Test within 3 minutes of collection. For ionized calcium use balanced heparin)
§
Fresh whole blood collected in a collection tube or syringe
with lithium or sodium heparin anticoagulant
(Fill tubes to capacity; fill syringes for correct blood to heparin
ratio)
(Test within 10 minutes of collection)
B. Specimen Labeling:
If the specimen is not analyzed
immediately after collection by the person collecting the specimen, the
specimen container must be labeled with the following information:
Patient name,
sex, age
Patient ID number
Time and date of collection
Doctor's name
C. Specimen Collection:
In‑Dwelling Line:
Back flush line with sufficient amount
of blood to remove intravenous solution, heparin, or medications that may
contaminate the sample.
Recommendation: three to six
times the volume of the catheter, connectors, and needle.
Arterial Specimens:
Fill blood gas syringe to the
recommended capacity or use the least amount of liquid heparin anticoagulant
that will prevent clotting.
Underfilling syringes containing liquid heparin will decrease results
due to dilution and will decrease ionized calcium results due to binding. For ionized calcium, balanced or low volume
heparin blood gas syringes are recommended.
Mix blood and anticoagulant by rolling
syringe between palms for at least 5 seconds and then inverting the syringe
repeatedly for at least 5 seconds.
Avoid or remove immediately any air drawn into syringe to maintain
anaerobic conditions. A blood sample
should be tested within 10 minutes after it has been obtained (remix before
testing).
Venous Specimens:
If a cartridge cannot be filled
immediately, collect sample into an evacuated blood collection tube or a
syringe containing heparin (sodium, lithium or balanced) anticoagulant. For ionized calcium measurements, balanced
heparin or 10 IU/mL of sodium or lithium heparin is recommended. Fill tubes to capacity; fill syringes for
correct blood to heparin ratio.
Incomplete filling causes higher heparin to blood ratio which will
decrease ionized calcium results and may affect other results.
Mix blood and anticoagulant by rolling
syringe between palms for at least 5 seconds and then inverting the syringe
repeatedly for at least 5 seconds. If
possible, test samples immediately after drawn; samples should be tested within
10 minutes (remix before testing).
Finger and Heelstick Specimens:
Wipe away the first drop of blood,
which contains excess tissue fluid which can increase potassium result and
dilute other test results. Avoid
drawing air into capillary tube.
Heparinized capillary tubes are not suitable for ionized calcium due to
the high concentration of heparin. Use
balanced heparin or plain capillary tubes for collection. Test samples immediately to avoid clotting
(especially in neonates).
D. Criteria For Specimen Rejection:
§
Evidence of clotting
§
Specimens collected in vacuum tubes with anticoagulant other
than lithium or sodium heparin
§
Syringe for pH, PCO2 and PO2 with air bubbles in sample
§
Incompletely filled vacuum tube for the measurement of
ionized calcium
§
Other sample types such as urine, CSF and pleural fluid
Avoid the Following Circumstances
§
Drawing a specimen from an arm with an I.V.
§
Stasis (tourniquet left on longer than one minute before
venipuncture)
§
Extra muscle activity (fist pumping)
§
Hemolysis (alcohol left over puncture site, or a traumatic
draw)
§
Icing before filling cartridge
§
Time delays before filling cartridge
§
Exposing the sample to air when measuring pH, PCO2 and PO2
Also, see the Anesthesia Department's
procedure "Blood Samples for
Testing on Departmental-based Equipment.”
V.
SUPPLIES & STORAGE REQUIREMENTS:
A. Cartridges:
Store the main supply of cartridges at
2 to 8°C. Do not allow cartridges to freeze.
Cartridges may be stored at room temperature (18 to 30°C) for 14
days. Cartridges should never be
returned to the refrigerator once they have been at room temperature, and
should not be exposed to temperatures above 30°C.
Mark the calendar on the box to indicate the two week room temperature
expiration date. Cartridges should
remain in pouches until time of use.
All cartridges that require thermal control at 370C should
stand at room temperature for four hours before use. Do not use after the labeled expiration date.
B. Controls:
§
I-STAT controls,
Level 1 and Level 3, are aqueous assayed controls intended to verify the
integrity of newly received I-STAT cartridges.
Each vial contains 5 ml of an aqueous buffered solution with
preservatives, electrolytes, glucose and urea equilibrated with precise
mixtures of O2, CO2,, and N2 gases. These solutions do not contain human serum
or serum products.
Store at 2 to 80C. Controls can be stored at room temperature
(20 to 300C) for 5 days. Do
not use beyond the expiration date on the box and ampule labels.
§
Hematronix Meter Trax Controls are assayed controls used to
monitor the accuracy and precision of hematocrits on various analyzers, the
I-STAT being one of them. Each vial
contains 2 ml of stabilized human red blood cells in a buffered medium
containing preservatives. This product should be handled with care
and considered potentially capable of transmitting infectious disease. Store upright at 2 to 80C. Do not freeze. Once opened vials may be used for 30 days provided they have been
resealed and refrigerated immediately after each use. Do not use after expiration date on box and vials. The control vials must be mixed very well
each time prior to use.
§
Electronic Simulator: a reusable quality control device that
simulates 2 levels of electrical signals which stress the analyzer's signal
detection functions. The simulator
provides a check on the ability of the analyzer to take accurate and sensitive
measurements of voltage, current and resistance from the cartridge. Store at room temperature and protect
contact pads from contamination by placing the Electronic Simulator in its protective
case.
VI.
INSTRUMENTATION:
A. Specifications:
Power:
Two 9-volt lithium batteries (expected life ~900 uses)
Calibration: Factory (electronic,
mechanical, thermal, pressure)
Memory/Clock back -up power: Lithium
battery
Display: Dot Matrix supertwist liquid
crystal
Communication Link: Infrared
light-emitting diode
Operating Temperature: 18 to 300C
Relative Humidity: 0-65% (minimum)
noncondensing
Storage of Results: Holds 50 test
records in memory
Software: Updated by I-STAT.
B. Keypad:
There are 15 labeled keys and two
smaller unlabeled keys (soft keys) located directly below the display screen:
DIS The display key
activated the display screen in order to call the most recently displayed test
results to the screen or to access the Menu page.
ENT The enter key is
pressed in response to a prompt on the display screen to complete an action.
CLR The clear key erases
an incorrect number when entering and identification number. The cursor back one space each time the key
is pressed.
0 - 9 The "0"
through "9" keys are used for identification numbers, date, time, and
to make selections from the menu options.
PRT The print key is
used to print selected test records.
* The * key has
several functions. It serves as a
decimal point, to send data to Central Data Station, exit a page, stop transmission
of test records to portable printer.
C. Softkeys:
The two softkeys directly below the
display screen are activated by the software when needed. When activated, the
soft key's function or label will
appear on the bottom of the screen, directly above the key.
PAGE This key is
pressed to access additional display screens when certain analyzer functions
require more space than a single screen allows.
MENU This key is
pressed to access the menu page. From
menu, status and stored results can be accessed.
CLKSET This key is
pressed to enter the clock-setting function.
This key is activated when the Status
page is displayed.
Page Page¯ Operator can page forward (8) and backward
(9) through the 10 pages of stored
results.
The Menu page has two numbered options,
Status and Stored Results.
Status: Contains
information such as date, time, BP, Serial #, battery voltage, # of uses,
software version, etc.
Stored
Results:
50 test records may be stored in memory.
Results can be displayed, printed, or transmitted to Laboratory
Information System.
D. Portable Printer:
Hewlett-Packard HP 82240B Infrared
Printer. Used to obtain a printout of a
test record at the point of care. The
printer is attached to a cradle in which the I-STAT rests on during
transmission. The printer operates on
four “AA” batteries.
VII.
TEST CYCLE:
The
test cycle is initiated by the insertion of a cartridge into the analyzer. During the test cycle the following
functions are performed by the analyzer:
§
Electrical contact is made with the cartridge.
§
Cartridge type is identified
§
Calibration fluid is released to the sensors.
§
Barometric pressure is measures.
§
Sensors are heated to 370C.
§
Electrical signals generated at the sensors are measure.
§
Calibrant solution is displaced with sample.
§
Electrical signals generated at the sensors are measured.
§
Operator and Patient ID numbers are accepted.
§
Blood gas parameters are accepted.
§
Results are calculated and displayed.
§
Results are stored.
VIII.
CALIBRATION:
Calibration
is automatically performed as part of the test cycle on each cartridge. Therefore, no further calibration
procedures, including calibration verification, are required. Every cartridge contains a sealed foil pack
which contains a calibrant solution with a known concentration of each
analyte. During the first part of the
testing cycle, the calibrant solution is automatically forced out of the foil
pack and over the sensors. The signals
produced by the sensors in response to the calibrant solution are stored. Once this sequence is completed, the
analyzer automatically moves the sample over the sensors. By comparing the sensors' response to the
sample with that of the calibrant, the concentration of each analyte in the
sample is calculated. An error message
will be displayed if calibration fails.
If calibration fails, patient results will not be displayed and the
sample will need to be reanalyzed with a new cartridge.
IX.
PROCEDURE FOR ANALYSIS:
A. Preparation for Use:
All cartridges should stand at room
temperature for 1 hour before use (an entire box). Individual cartridges can be used after standing just 5 minutes
at room temperature.
Verify Refrigerated Cartridges
§
Verify that the cartridges stored in the refrigerator are
all within the expiration date printed on the boxes.
§
Verify that the refrigerator did not exceed the limits of 2
to 8°C. If the
temperature of the cartridge storage refrigerator is within the range of 2 to 8°C use
cartridges as required.
§
If the temperature is outside the range of 2 to 8°C, quarantine
the cartridges in the storage refrigerator and do not use.
Verify Room Temperature Cartridges:
§
Verify that all boxes of cartridges at room temperature have
been out of the refrigerator less than two weeks. Do not use any expired cartridges.
B. Operating Procedure:
1.
Remove the cartridge from its pouch.
Avoid touching the contact pads or exerting pressure over the calibrant
pack in the center of the cartridge.
2. Direct the dispensing tip or
capillary tube containing the blood into the sample well.
3. Dispense the sample until it reaches
the FILL TO mark on the cartridge.
Leave some sample in the well.
4. Close the cover over the sample well
until it snaps into place. (Do not
press over the sample well.)
5. Insert the cartridge into the
cartridge door until it clicks into place.
6. Enter an operator ID number up to 7
digits. Repeat the process for
verification.
7. Enter the patient ID number (6 digit
Medical Record #). Repeat the process
for verification.
8. Enter the parameters (if required)
for cartridges requiring thermal control; Patient temperature can be entered as
degrees Centigrade or Fahrenheit. Use
the * key for a decimal point. %FIO2
can be entered as the number of liters or as a percentage of the oxygen a patient
is receiving.
9. Choose the number corresponding to
the type of sample used when prompted at the Sample Type field.
10. Press the SAVE softkey to record
the blood gas parameters entered.
11. View results shown on the
analyzer's display screen.
X.
RESULTS:
A. Calculations:
The I‑STAT analyzer contains a
microprocessor that performs all calculations required for reporting results.
B. Suppressed Results:
There are three conditions under which
the I‑STAT System will not display results:
1. Results outside the System's
reportable ranges are flagged with a "<" or ">",
indicating that the result is below the lower limit or above the upper limit of
the reportable range respectively. See
the table of Reportable Ranges.
2. Results which are unreportable based
on internal QC rejection criteria are flagged with"****". Analyze the specimen again using another
cartridge. The results that are not
suppressed should be reported in the usual manner.
3. Results will not be reported if a
test cycle has a problem with the sample, calibrant solution, sensors,
mechanical or electrical functions of the analyzer.
Refer
to the I-STAT System Manual's Troubleshooting section.
XI.
REPORTING RESULTS:
A. Printing Results:
1. Place the analyzer in the cradle of
an IR Interface, IR Link or IR Cradle.
Turn the printer on (printer light green) or press the paper advance
switch to reactivate.
2. To print the displayed test record,
press the PRT key on the analyzer.
3. Do not move the analyzer while
"Printing" is displayed.
Note: Results printed on thermal paper
will fade with time and are therefore not acceptable as a permanent chartable
record.
4. Write the patient's name on the
"Pt name line" and the physician's name on the Physician line.
B. Transmitting Results to the Central
Data Station:
1. Place the analyzer in the cradle of
an IR Interface or Link. The IR status
light must be green.
2. To transmit the displayed test
record, press the * key.
3. To transmit all stored test records,
access STORED RESULTS from the menu.
Press the "3" key on the analyzer to transmit all test
records.
4. Do not move the analyzer while
"Transmitting" is displayed.
During transmission the IR Status light will blink alternately red and
green. If transmission is successful,
the IR Link will emit a single high pitched beep and the light will return to
green. An unsuccessful transmission is
indicated by three low tone beeps. In
this case repeat the transmission process.
If unsuccessful the second time, notify the point-of-care coordinator at
pager #0616.
5. Successful transmissions will
automatically be sent to Sunquest, the Laboratory Information System. Billing will occur simultaneously.
C. Anesthesiologists performing
analysis will receive results in 2 minutes.
Anesthesiologists who order the test but do not perform the analysis,
will receive all results within 5 minutes.
XII.
REFERENCE RANGES / CRITICAL RANGES / REPORTABLE RANGES:
ANALYTE |
UNIT |
REFERENCE RANGE |
CRITICAL RANGE |
LINEARITY RANGE |
||
SODIUM |
mmol/L |
134-146 |
115-155 |
100-180 |
||
POTASSIUM |
mmol/L |
Age 0 2D 1 M 3 M >16 Y |
5.0-7.5 4.0-5.9 4.0-6.2 3.5-5.3 3.5-5.5 |
3.0-7.0 |
2.0-9.0 |
|
CHLORIDE |
mmol/L |
98-108 |
80-122 |
65-140 |
||
BUN |
mg/dL |
Age 0 2 Y 16 Y |
5-15 7-18 5-15 |
4-50 |
3-140 |
|
GLUCOSE |
mg/dL |
Age 0 1 M 1 Y 16 Y |
40-80 60-110 70-110 60-110 |
40-300 |
20-450 |
|
IONIZED CA |
mmol/L |
1.12-1.32 |
0.74-1.57 |
0.25-2.50 |
||
pH (ARTERIAL) |
|
Age 0 >1 D |
7.29-7.45 7.35-7.45 |
|
6.8-8.0 |
|
PCO2 (ARTERIAL) |
mmHg |
35-45 |
|
10-100 |
||
PO2 (ARTERIAL) |
mmHg |
Age 0 1 D |
54-95 83-103 |
|
0-800 |
|
HEMATOCRIT |
% |
Age 0 1 D 7 D 14 D 1 M 2 M 3 M 6 M 2 Y 6 Y 12 Y >18 Y |
MALE 42-60 45-67 42-66 39-63 31-55 28-42 29-41 33-39 34-40 35-45 37-49 41-53 |
FEMALE 42-60 45-67 42-66 39-63 31-55 28-42 29-41 33-39 34-40 35-45 36-46 36-46 |
20-60 |
10-75 |
HCO3* (ARTERIAL) |
mmol/L |
Age 0-2 D 2 D - 1 M 1 M - 16 Y >16 Y |
13-22 20-27 23-30 24-30 |
|
1-85 |
|
TCO2* (VENOUS) |
mmol/L |
19-24 |
|
1-85 |
||
SBE* (ARTERIAL EXTRACELLULAR) |
mmol/L |
-2 to +3 |
|
N/A |
||
ANION GAP* (VENOUS) |
mmol/L |
10-20 |
|
-10 to 20 |
||
sO2 * |
% |
95-99 |
|
N/A |
||
HEMOGLOBIN* |
g/dL |
Age 0 1 D 7 D 14 D 1 M 2 M 3 M 6 M 2 Y 6 Y 12 Y 18 Y |
MALE 13.5-19.5 14.5-22.5 13.5-21.5 12.5-20.5 10-18 9-14 9.5-13.5 10.5-13.5 11.5-13.5 11.5-15.5 13-16 13.5-17.5 |
FEMALE 13.5-19.5 14.5-22.5 13.5-21.5 12.5-20.5 10-18 9-14 9.5-13.5 10.5-13.5 11.5-13.5 11.5-15.5 12-16 12-16 |
6-20 |
3-26 |
* Calculated values
XIII.
DAILY QUALITY CONTROL:
A. Rationale:
Traditional quality control methods,
based on analysis of controls in every "run" of patient samples, were
designed to detect persistent changes in performance of multiple-use analytical
systems which deteriorate with time or usage.
However, in a single-use analytical system such as the I-STAT, the
analytical units are not reused and subject to deterioration caused by previous
samples or reagents. Each new cartridge
presents a fresh analytical path for each specimen. A homogenous batch of I-STAT cartridges, verified when newly
received and stored properly thereafter, will retain its collective performance
at least until its expiration date.
B. Daily QC Procedure:
ELECTRONIC SIMULATOR
1.Verify the performance of each
analyzer in the I-STAT system using the Electronic Simulator every 8 hours of use. The SIM message will appear as a reminder if
8 hours have elapsed since the last electronic simulator test.
2. If
PASS is displayed on the
screen:
§
Remove the Electronic Simulator after the LCK message
disappears from the display screen.
§
Transmit the result to the Central Data Station.
§
Use the analyzer as required.
3. If FAIL is displayed on the analyzer screen:
§
Record the failure in the I-STAT System Electronic Simulator
Action Log (See attached).
§
.Repeat the procedure with the same Electronic
Simulator.
§
If code "L" appears with failure, this may be an
indication that moisture may be on the internal connector. In this case, allow the analyzer to sit for
half an hour to allow the moisture to evaporate, then insert Electronic
Simulator again.
§
If failure still occurs, call the point-of-care coordinator
at pager 4431 or ext. 4431 first. If
she/he is not available, call the I-STAT technical service at 1-800-366-8020.
§
Do not use
analyzer if simulator fails.
B. Monthly Procedure:
Print Electronic Simulator results
using the trend function on the Central Data Station.
XIV.
PERIODIC QUALITY CONTROL PROCEDURES:
For
acceptance of newly received cartridge lots, perform the following:
A.
Check Temperature Monitor:
§
I‑STAT cartridges are shipped refrigerated with a four
window indicator to monitor temperature during transit.
§
Fill out the record of receipt and forward materials to
refrigerator.
§
If all windows are white or if only the "A" window
is blue, then transit temperatures were satisfactory.
§
If any or all of the "B", "C", or
"D" windows are blue, quarantine the suspect cartons and notify the
point-of-care coordinator immediately.
§
DO NOT USE cartridges from the suspect cartons.
§
Record the out of control event in the I‑STAT QC Log
(See attached).
B.
Integrity Testing:
§
From each lot of cartridges received, analyze I‑STAT
Level 1 and 3 and Meter Trax Low and High controls each in duplicate, using any
verified analyzer. Transmit the results
to the Central Data Station.
§
Use the expected values published in the package inserts to
verify the integrity of the cartridges.
1. Procedure for G, E3+, EC4+ and 6+
cartridges:
a. Remove I-STAT ampule(s), Metertrax
controls and cartridge(s) from the refrigerator and allow all to come to room
temperature (approximately 30 minutes).
Tap the tip of the ampule to send any solution back into body. Carefully snap off the neck of the ampule
and draw solution from the body of the ampule using a fresh capillary tube or
sterile 1‑3cc syringe with 20 gauge needle. Expel approximately one or two drops of solution into cartridge
until solution reaches the fill to line on the cartridge. Close the cartridge and insert into the
analyzer. Metertrax controls are to be
mixed very well prior to use and are dispensed directly into the cartridge.
b. The contents of one ampule may be
used to fill more than one cartridge as long as it is used within 10 minutes of
opening. Always use a fresh syringe or
capillary tube for each level of solution.
c.
Enter the identification number assigned to the control in the patient
identification field:
§
Level 1 = 10
§
Level 3 = 30
§
Low Metertrax = 40
§
High Metertrax = 50
d. Compare results to the package
insert values. Check that the lot
number on the control ampule matches the lot number on the package insert, and
that the software version listed on the insert matches the software installed
in the analyzer. If all results are
within expected ranges use the cartridges as needed.
e. Record all results on the I-STAT System QC
Log.
f. Transmit the results to the Central Data
Station.
2. Procedure for G3+, EG6+, EC6+, EG7+ and EC8+ cartridges:
a. Remove I-STAT QC ampule(s) and
cartridge(s) and Metertrax controls from the refrigerator and allow to come to
room temperature (minimum 4 hours for ampule(s) and cartridges).
b.
Shake the ampule vigorously for 10 seconds to equilibrate the liquid and
gas phases. Tap the top of the ampule
to send any solution back into body.
c. Carefully snap off the neck of the
ampule, and immediately draw solution from the body of the ampule using a fresh
capillary tube or sterile 1‑3cc syringe with 20 gauge needle. It is
important not to expose the solution to room air since this will alter the
results. If air is trapped near the
plunger, do not invert the syringe to expel it; this air will not affect
solution to be used at the tip of the syringe.
If bubbles are continually drawn in the syringe and near the tip,
discard and use a fresh ampule and syringe.
d. Expel two drops from the syringe or
capillary tube into a gauze pad. Then
place two to four drops of the solution into the cartridge. Be sure that the solution reaches the FILL
TO line. Metertrax controls are to be
mixed very well prior to use and are dispensed directly into the
cartridges.
e. Close the cartridge and insert into
the analyzer. Use one ampule for each
cartridge to be tested. An ampule
should not be used more than once.
f.
Enter the identification number assigned to the control solution in the
patient identification field:
§
Level 1 = 10
§
Level 3 = 30
§
Low Metertrax = 40
§
High Metertrax = 50
g. Perform each level of control two
times
h. Compare results to the package insert values. Check that the lot number on the control ampule matches the lot number on the package insert and that the software version listed on the insert matches the software installed in the analyzer. If all results are within expected ranges use the cartridges as needed.
i. Record all results on I-STAT System
QC log.
j. Transmit the results to the Central
Data Station.
3. Remedial Action:
If any results are outside the
published expected ranges:
§
DO NOT USE cartridges from the suspect lot.
§
Quarantine the suspect lot.
§
Notify the point-of-care coordinator immediately.
§
Record the QC failure in the I‑STAT QC Action Log
along with the action taken.
XV.
CALIBRATION VERIFICATION:
The
I-STAT Corporation suggests that Calibration Verification is not required
because each I-STAT cartridge contains a calibrant solution and therefore, the
requirement by CLIA for a calibration procedure is met each time a cartridge is
run.
XVI.
COMPETENCY CHECKS:
Competency
checks will be performed on each operator annually by a representative from the
I-STAT Corp, the Coordinator of Point-of-Care Testing, or the Anesthesia Nurse
Coordinator.
XVII.
PROFICIENCY TESTING:
Proficiency
testing will be provided by CAP. The
survey performed on the EG6+, EG7+ and G cartridges will be the Aqueous Blood
Gas (AQ) survey which provides five challenges three times per year. PT will be performed by routine operators.
Results
will be received and reviewed by the Director of Clinical Pathology. Results will be communicated to the
anesthesia department via the Point-of-Care Coordinator.
XVIII.
LIMITATIONS:
Below
is a list of interfering substances which can cause erroneous results on the
following analytes:
ANALYTE |
INTERFERANT |
INTERFERANT
CONCENTRATION |
EFFECT ON
ANALYTE RESULT |
Sodium |
b-hydroxybutyrate |
16 mmol/L |
¯ Na by 4
mmol/L |
Chloride |
b-hydroxybutyrate Bromide Lactate Salicylate |
16 mmol/L 12.5 mmol/L 11 mmol/L 4 mmol/L |
¯ Cl by 6
mmol/L Cl by 30
mmol/L Cl by 3.5
mmol/L Cl by 3
mmol/L |
Ionized
Calcium |
Magnesium |
1.0 mmol/L |
iCa by
0.04 mmol/L |
Glucose |
Ammonium Bromide pH Oxygen |
0.5 mmol/L 12.5 mmol/L pH: 7.2@370C pH: 7.6@370C PO2<20
mmHg @ 370C |
¯ Glu by 20% ¯ Glu by 55
mg/dL ¯ Glu by 4
mmol/L Glu by 1 mmol/L May
¯ Glu |
Hematocrit |
WBC Count Total
Protein |
> 50,000
WBC /Fl For Hct < 40% For each
g/dL below 7 For each
g/dL above 7 For Hct
> 40% For each
g/dL below 7 For each
g/dL above 7 |
May
Hct ¯ Hct by 1% Hct by 1% ¯ Hct by
0.75% Hct by
0.75% |
XIX.
CORRELATIONS WITH OTHER BLOOD GAS ANALYZERS:
Correlations
of a whole blood sample will be performed on the I-STAT and on an analyzer of
different methodologies every 6 months.
Tonometry of EQUIL has proven not to work on the I-STAT.
XX.
REFERENCES:
I-STAT
Controls 1,2, and 3 package insert, I-STAT Corp., Sept 1995
I-STAT
Calibration Verification Set package insert, I-STAT Corp., Sept 1995
I-STAT
System Manual
MeterTrax
package insert, Hematronix, Inc., May,
1995
Fundamentals
of Clinical Chemistry, N. Tietz, Third Edition, Pages :426-435, 614-616, and 676-678.
Clinical
Chemistry Theory, Analysis & Correlation, Kaplan/Pesce, Second Edition, Pages 850-856, 872-875,
884-888, and 1021-1024.
Barry
A. Shapiro, M.D., William T. Peruzzi, M.D., Rozanna Kozelowski-Templin,
C-C.P.T., C.P.F.T.: Clinical Applications of Blood Gases, 5th Ed., 1994,
p.55-65.
Anesthesia
for Infants and Children, Smith's, 5th Ed., Etsuro K. Motoyama, Ed. p.23, 434
Nelson
book of Pediatrics, 12th Ed., Behrman, M.D. Ed., Appendix tables 29-2, p.1831,
1844, 1845
Anesthesia,
2nd ED., Ronald Miller, Ed. p.425, 427
Manual
of Pediatric Anesthesia, 3rd ED., David J. Steward, Ed., p.18, 33
Clinical
Anesthesia Procedures of the Massachusetts General Hospital, 3rd Ed., Leonard L.
Firestone, Ed., p.388
Clinical
Diagnosis and Management by Laboratory Methods, 16th Ed., John B. Henry,
Ed. p.116-132
Textbook
of Clinical Chemistry, 1986 Ed., Norbert W. Tietz,Ph.D., Ed., p.1191-1220
XX.
SUPPLEMENTAL MATERIALS (attached):
A. Analyzer coded messages
B. i-STAT Electronic Simulator Action
Log
C. i -STAT System QC Log: Incoming QC
D. i-STAT System QC Log: Expiration
Date and Storage Conditions
E. i-STAT Skills Checklist for
Competency